Araclon Biotech
Araclon Biotech, a subsidiary of Grifols, is a company specializing in the research and development of methods for the early diagnosis and preventive treatment of Alzheimer’s Disease.
We are pioneers in the development of assays based on the determination of amyloid peptides in plasma that help to detect early pathological changes of the disease, before the onset of symptoms.
Araclon Biotech
Araclon Biotech, a subsidiary of Grifols, is a company specializing in the research and development of methods for the early diagnosis and preventive treatment of Alzheimer’s Disease.
We are pioneers in the development of assays based on the determination of amyloid peptides in plasma that help to detect early pathological changes of the disease, before the onset of symptoms.
Services and R&D
ABtest-Service
The safest way to obtain reliable results from automated analysis under strictly standardized conditions and performed by highly qualified personnel.
Diagnosis
At Araclon Biotech we have developed a state-of-the-art assay that allows the simultaneous determination of total Aβ40 and Aβ42 levels.
Treatment
ABvac40 is an active vaccine against Aβ40 peptide for the preventive treatment of Alzheimer's Disease.
How can we help you?
Contact the Araclon Biotech team.